Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DFFN Diffusion Pharmaceuticals

5.650
+0.010+0.18%
Close 10/06 16:00 ET
5.6500.0000.00%
Post Mkt Price 10/06 19:08 ET
High
5.800
Open
5.800
Turnover
29.46K
Low
5.453
Pre Close
5.640
Volume
5.26K
Market Cap
11.52M
P/E(TTM)
Loss
52wk High
25.240
Shares
2.04M
P/E(Static)
Loss
52wk Low
5.100
Float Cap
11.50M
Bid/Ask %
0.00%
Historical High
2249999775.000
Shs Float
2.03M
Volume Ratio
1.64
Historical Low
5.100
Dividend TTM
--
Div Yield TTM
--
P/B
0.43
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.26%
Amplitude
6.15%
Avg Price
5.604
Lot Size
1
Float Cap
11.50M
Bid/Ask %
0.00%
Historical High
2249999775.000
Shs Float
2.03M
Volume Ratio
1.64
Historical Low
5.100
Dividend TTM
--
P/B
0.43
Dividend LFY
--
Turnover Ratio
0.26%
Amplitude
6.15%
Avg Price
5.604
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
CEO: Dr. Robert Joseph Cobuzzi, Jr,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...